Corporate legal teams and compliance officers in research institutions should note the Department of Health and Human Services (HHS) has finalized significant revisions to its research misconduct regulations under the Office of Research Integrity (ORI). This is the first major update in almost 20 years to the Code of Federal Regulations (42 CFR part 93), governing inquiries into research integrity. The final rule introduces clarity on several vital points, addressing issues that had remained ambiguous under the previous regulations.
Key updates include a more precise definition of “recklessness” in research misconduct cases. According to the new rule, “recklessness” involves conducting or reporting research with indifference to known risks of fabrication, falsification, or plagiarism. This update raises crucial questions about the responsibility of senior researchers for overseeing the work of their junior colleagues and ensuring accurate and truthful research outcomes.
The new rule also mandates the transcription and sharing of witness interviews during the investigative stage of misconduct proceedings. While this could enhance the respondent’s ability to mount a defense, it may also deter junior scientists from testifying against senior colleagues due to a fear of retribution. Institutions are advised to consider protective measures, such as redactions, to safeguard the identities of witnesses. The ORI’s guidance suggests that redactions could help, but this might not always be sufficient to protect witnesses’ identities in practical scenarios.
Another critical amendment concerns the “subsequent use exception,” which alters the six-year limitation period for investigating research misconduct allegations. This exception will now be confined to instances where the respondent uses or cites the specific portions of research that are alleged to be fabricated, falsified, or plagiarized. This narrower scope might complicate fact-finding, given the generality with which citations are often made in scientific literature and grant applications.
The final rule also revises the standards for respondent records production. In prior regulations, failing to maintain or provide research records could be taken as evidence of misconduct if intent was established. Under the new rule, the failure to provide records is considered evidence of misconduct only if the respondent claims to have the records but refuses to release them upon request. This revision could pose challenges for institutions trying to pin down non-cooperation as an act of misconduct.
Institutions affected by these changes, which come into effect for allegations received on or after January 1, 2026, must revises their policies and submit compliance documentation to the ORI by April 30, 2026. Until the ORI releases sample policies, institutions might want to proactively address these updates in their internal frameworks and guidelines. Insights into how these changes were received and described can be found in a detailed analysis.
The final rule and impending compliance deadlines necessitate institutions to re-evaluate their current policies, focusing on the supervision of research, the integrity of data, and the protection of potential whistleblowers. Strengthening institutional policies to prevent research misconduct not only enhances compliance but also rebuilds public trust, which has been waning amidst high-profile research scandals, as highlighted by a recent survey demonstrating declining trust in scientists.